Watchlist Price Alert

Apogee Therapeutics Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

44.47

2.61 (6.24%)

At close: Jun 13, 2025, 3:59 PM

44.48

0.02%

After-hours: Jun 13, 2025, 04:44 PM EDT

Apogee Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	36K	65K	65K	65K	29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-36K	-65K	-65K	-65K	-29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-241.78M	-216.87M	-178.14M	-143.76M	-118.53M	-93M	-69.95M	-56.15M	-39.08M	-30.73M	-16.63M	-6.12M	-4.3M
Interest Income	28.66M	34.74M	31.48M	25.28M	14.97M	9.02M	3.69M	225K	225K	92K	n/a	n/a	n/a
Pretax Income	-150.12M	-182.13M	-146.66M	-118.48M	-103.55M	-83.98M	-66.26M	-65.07M	-48.01M	-39.78M	-25.78M	-6.12M	-4.3M
Net Income	-150.05M	-182.15M	-146.66M	-118.48M	-103.55M	-83.98M	-66.26M	-65.07M	-48.01M	-39.78M	-25.78M	-6.12M	-4.3M
Selling & General & Admin	56.25M	48.98M	41.52M	35.79M	29.81M	24.58M	18.27M	11.65M	7.08M	2.94M	1.05M	428K	60K
Research & Development	185.54M	167.87M	136.59M	107.94M	88.69M	68.42M	51.68M	44.49M	32M	27.79M	15.58M	5.69M	4.25M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	241.78M	216.84M	178.12M	143.73M	118.5M	93M	69.95M	56.15M	39.08M	30.73M	16.63M	6.12M	4.3M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.15M	9.15M	9.15M	9.15M	n/a	n/a
Selling & Marketing Expenses	n/a	-29K	-29K	-29K	-29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	178.69M	216.87M	178.14M	143.76M	118.53M	93M	69.95M	56.15M	39.08M	30.73M	16.63M	6.12M	4.3M
Income Tax Expense	-65K	3.72K	-51.43K	3.45M	3.43M	3.44M	3.51M	-4.93K	13.96K	26.61K	-10.51K	n/a	n/a
Shares Outstanding (Basic)	58.2M	55.19M	56.8M	56.52M	50.19M	50.66M	50.67M	50.67M	50.67M	50.67M	50.67M	50.67M	50.67M
Shares Outstanding (Diluted)	58.2M	55.19M	56.8M	56.52M	50.19M	50.66M	50.67M	50.67M	50.67M	50.67M	50.67M	50.67M	50.67M
EPS (Basic)	-3.63	-3.32	-2.73	-2.28	-2.05	-1.66	-1.31	-1.29	-0.96	-0.79	-0.51	-0.12	-0.09
EPS (Diluted)	-3.63	-3.32	-2.73	-2.28	-2.05	-1.66	-1.31	-1.29	-0.96	-0.79	-0.51	-0.12	-0.09
EBITDA	-241.63M	-216.68M	-172.61M	-134.81M	-109.61M	-71.46M	-39.73M	-18.89M	n/a	n/a	n/a	n/a	n/a
EBIT	-178.69M	-216.87M	-172.72M	-134.88M	-109.64M	-84.12M	-66.39M	-56.06M	-38.99M	-30.64M	-16.63M	-6.12M	-4.3M
Depreciation & Amortization	160K	189K	37.27M	61.52M	80.37M	93M	72.74M	58.94M	41.87M	33.52M	16.63M	6.12M	4.3M